Aptiom 400 mg (Eslicarbazepine Acetate TABLET) 400 MG

Aptiom 400 mg tablets contain eslicarbazepine acetate, an anticonvulsant used to manage certain types of seizures. This medication is designed to help control epileptic activity in the brain.

Strength

400 MG

Manufacturer / TM Owner

SUMITOMO PHARMA CANADA, INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Aptiom 400 mg tablets are primarily used as an adjunctive therapy for partial-onset seizures in adults. Eslicarbazepine acetate works by stabilizing electrical activity in the brain, which can help reduce the frequency and severity of seizures. This medication is often prescribed when other treatments have not been fully effective.

Side Effects

Common effects of Aptiom 400 mg tablets may include dizziness, nausea, and fatigue. Some users may also experience headaches or double vision. These effects can vary from person to person and may diminish over time as the body adjusts to the medication.

Precautions & Warnings

Aptiom 400 mg tablets should be handled with care, especially for those with a history of allergic reactions to eslicarbazepine acetate or similar drugs. It is important to follow the prescribed dosage and consult a healthcare provider before making any changes to your medication regimen.

Avoid Interactions

Aptiom 400 mg tablets may interact with other medications, including those metabolized by the liver's cytochrome P450 system. Alcohol and certain anticonvulsants can also affect the efficacy and safety of eslicarbazepine acetate. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Aptiom 400 mg tablets are used as an adjunctive treatment for partial-onset seizures in adults.

Aptiom 400 mg tablets are taken orally, typically once daily, with or without food.

Common side effects may include dizziness, nausea, fatigue, headaches, and double vision.

Aptiom 400 mg may interact with other medications, so it's important to consult a healthcare provider before combining it with other drugs.

Aptiom 400 mg should be used with caution in individuals with a history of allergic reactions to eslicarbazepine acetate or similar drugs.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.